Stay updated on IPI-145 Plus FCR in CLL Clinical Trial
Sign up to get notified when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.

Latest updates to the IPI-145 Plus FCR in CLL Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe revision label on the page footer changed from v3.3.1 to v3.3.2.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page now shows Revision: v3.3.1, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the government funding lapse and NIH operating status notice from the page.SummaryDifference0.4%

- Check43 days agoChange DetectedUpdates appear to be minor UI/formatting adjustments to the Study Details page and do not modify core study information (eligibility criteria, outcomes, or trial status). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedUpdate to v3.2.0 with a government-operating status notice; removal of a specific genetic disease resource (B-cell CLL).SummaryDifference4%

- Check79 days agoChange DetectedUpgrade version from v3.0.2 to v3.1.0; no other content changes are specified.SummaryDifference0.1%

Stay in the know with updates to IPI-145 Plus FCR in CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.